Literature DB >> 29325110

Impact of genetic risk loci for multiple sclerosis on expression of proximal genes in patients.

Tojo James1,2, Magdalena Lindén1,2,3, Hiromasa Morikawa2,4,5, Sunjay Jude Fernandes2,4, Sabrina Ruhrmann1,2, Mikael Huss6, Maya Brandi6, Fredrik Piehl1,2, Maja Jagodic1,2, Jesper Tegnér2,4,5,7, Mohsen Khademi1,2, Tomas Olsson1,2, David Gomez-Cabrero4,8,9, Ingrid Kockum1,2.   

Abstract

Despite advancements in genetic studies, it is difficult to understand and characterize the functional relevance of disease-associated genetic variants, especially in the context of a complex multifactorial disease such as multiple sclerosis (MS). As a large proportion of expression quantitative trait loci (eQTLs) are context-specific, we performed RNA-Seq in peripheral blood mononuclear cells from MS patients (n = 145) to identify eQTLs in regions centered on 109 MS risk single nucleotide polymorphisms and 7 associated human leukocyte antigen variants. We identified 77 statistically significant eQTL associations, including pseudogenes and non-coding RNAs. Thirty-eight out of 40 testable eQTL effects were colocalized with the disease association signal. As many eQTLs are tissue specific, we aimed to detail their significance in different cell types. Approximately 70% of the eQTLs were replicated and characterized in at least one major peripheral blood mononuclear cell-derived cell type. Furthermore, 40% of eQTLs were found to be more pronounced in MS patients compared with non-inflammatory neurological diseases patients. In addition, we found two single nucleotide polymorphisms to be significantly associated with the proportions of three different cell types. Mapping to enhancer histone marks and predicted transcription factor binding sites added additional functional evidence for eight eQTL regions. As an example, we found that rs71624119, shared with three other autoimmune diseases and located in a primed enhancer (H3K4me1) with potential binding for STAT transcription factors, significantly associates with ANKRD55 expression. This study provides many novel and validated targets for future functional characterization of MS and other diseases.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29325110     DOI: 10.1093/hmg/ddy001

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  16 in total

1.  ETV7 limits antiviral gene expression and control of influenza viruses.

Authors:  Heather M Froggatt; Alfred T Harding; Ryan R Chaparian; Nicholas S Heaton
Journal:  Sci Signal       Date:  2021-07-13       Impact factor: 8.192

Review 2.  B and T Cells Driving Multiple Sclerosis: Identity, Mechanisms and Potential Triggers.

Authors:  Jamie van Langelaar; Liza Rijvers; Joost Smolders; Marvin M van Luijn
Journal:  Front Immunol       Date:  2020-05-08       Impact factor: 7.561

3.  DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis.

Authors:  Lara Kular; Yun Liu; Sabrina Ruhrmann; Galina Zheleznyakova; Francesco Marabita; David Gomez-Cabrero; Tojo James; Ewoud Ewing; Magdalena Lindén; Bartosz Górnikiewicz; Shahin Aeinehband; Pernilla Stridh; Jenny Link; Till F M Andlauer; Christiane Gasperi; Heinz Wiendl; Frauke Zipp; Ralf Gold; Björn Tackenberg; Frank Weber; Bernhard Hemmer; Konstantin Strauch; Stefanie Heilmann-Heimbach; Rajesh Rawal; Ulf Schminke; Carsten O Schmidt; Tim Kacprowski; Andre Franke; Matthias Laudes; Alexander T Dilthey; Elisabeth G Celius; Helle B Søndergaard; Jesper Tegnér; Hanne F Harbo; Annette B Oturai; Sigurgeir Olafsson; Hannes P Eggertsson; Bjarni V Halldorsson; Haukur Hjaltason; Elias Olafsson; Ingileif Jonsdottir; Kari Stefansson; Tomas Olsson; Fredrik Piehl; Tomas J Ekström; Ingrid Kockum; Andrew P Feinberg; Maja Jagodic
Journal:  Nat Commun       Date:  2018-06-19       Impact factor: 14.919

4.  Multi-drug use among patients with multiple sclerosis: A cross-sectional study of associations to clinicodemographic factors.

Authors:  Niklas Frahm; Michael Hecker; Uwe Klaus Zettl
Journal:  Sci Rep       Date:  2019-03-06       Impact factor: 4.379

5.  Quantitative proteomic analyses of CD4+ and CD8+ T cells reveal differentially expressed proteins in multiple sclerosis patients and healthy controls.

Authors:  Tone Berge; Anna Eriksson; Ina Skaara Brorson; Einar August Høgestøl; Pål Berg-Hansen; Anne Døskeland; Olav Mjaavatten; Steffan Daniel Bos; Hanne F Harbo; Frode Berven
Journal:  Clin Proteomics       Date:  2019-05-08       Impact factor: 3.988

6.  Polypharmacy in outpatients with relapsing-remitting multiple sclerosis: A single-center study.

Authors:  Niklas Frahm; Michael Hecker; Uwe Klaus Zettl
Journal:  PLoS One       Date:  2019-01-24       Impact factor: 3.240

7.  A genetic variant associated with multiple sclerosis inversely affects the expression of CD58 and microRNA-548ac from the same gene.

Authors:  Michael Hecker; Nina Boxberger; Nicole Illner; Brit Fitzner; Ina Schröder; Alexander Winkelmann; Ales Dudesek; Stefanie Meister; Dirk Koczan; Peter Lorenz; Hans-Jürgen Thiesen; Uwe Klaus Zettl
Journal:  PLoS Genet       Date:  2019-02-07       Impact factor: 5.917

8.  Eliciting priors and relaxing the single causal variant assumption in colocalisation analyses.

Authors:  Chris Wallace
Journal:  PLoS Genet       Date:  2020-04-20       Impact factor: 5.917

9.  Interactome of the Autoimmune Risk Protein ANKRD55.

Authors:  Nerea Ugidos; Jorge Mena; Sara Baquero; Iraide Alloza; Mikel Azkargorta; Felix Elortza; Koen Vandenbroeck
Journal:  Front Immunol       Date:  2019-09-18       Impact factor: 7.561

Review 10.  Changes in Deoxyribonucleic Acid Methylation Contribute to the Pathophysiology of Multiple Sclerosis.

Authors:  Naiara Celarain; Jordi Tomas-Roig
Journal:  Front Genet       Date:  2019-11-12       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.